Mandar Shashikant Bhagwat, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brachytherapy | 8 | 2024 | 1236 | 1.290 |
Why?
|
Eye Neoplasms | 1 | 2022 | 306 | 0.710 |
Why?
|
Cone-Beam Computed Tomography | 3 | 2015 | 471 | 0.420 |
Why?
|
Radiotherapy Dosage | 9 | 2024 | 2896 | 0.410 |
Why?
|
Radiometry | 4 | 2015 | 813 | 0.400 |
Why?
|
Radiotherapy, Conformal | 2 | 2011 | 549 | 0.350 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 5 | 2017 | 1659 | 0.300 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2024 | 881 | 0.220 |
Why?
|
Melanoma | 1 | 2022 | 5691 | 0.220 |
Why?
|
Models, Theoretical | 2 | 2011 | 3561 | 0.200 |
Why?
|
Physical Phenomena | 1 | 2020 | 48 | 0.180 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2167 | 0.170 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2017 | 2016 | 0.170 |
Why?
|
Scattering, Radiation | 2 | 2011 | 488 | 0.160 |
Why?
|
Catheters | 1 | 2020 | 421 | 0.140 |
Why?
|
Radiation Protection | 1 | 2021 | 425 | 0.140 |
Why?
|
Protons | 1 | 2022 | 1112 | 0.140 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2016 | 66 | 0.130 |
Why?
|
Mouth Neoplasms | 1 | 2021 | 593 | 0.130 |
Why?
|
Phantoms, Imaging | 3 | 2015 | 2509 | 0.130 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 830 | 0.120 |
Why?
|
Software Validation | 1 | 2014 | 59 | 0.120 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2010 | 801 | 0.110 |
Why?
|
Radiation Injuries | 1 | 2021 | 1182 | 0.110 |
Why?
|
Air | 2 | 2011 | 186 | 0.110 |
Why?
|
Cystadenocarcinoma, Papillary | 1 | 2012 | 56 | 0.110 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2012 | 217 | 0.090 |
Why?
|
Film Dosimetry | 1 | 2010 | 29 | 0.090 |
Why?
|
Particle Accelerators | 1 | 2011 | 174 | 0.090 |
Why?
|
Filtration | 1 | 2011 | 227 | 0.090 |
Why?
|
Water | 2 | 2010 | 1402 | 0.070 |
Why?
|
Organs at Risk | 2 | 2021 | 358 | 0.070 |
Why?
|
Skin | 1 | 2020 | 4464 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2014 | 20052 | 0.070 |
Why?
|
Radiobiology | 1 | 2024 | 89 | 0.060 |
Why?
|
Uterine Neoplasms | 1 | 2012 | 1439 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2012 | 1357 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4023 | 0.050 |
Why?
|
Quality Control | 2 | 2015 | 825 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6313 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9273 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1573 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2021 | 656 | 0.040 |
Why?
|
Calibration | 2 | 2010 | 814 | 0.040 |
Why?
|
Humans | 11 | 2024 | 758381 | 0.030 |
Why?
|
Colon, Sigmoid | 1 | 2017 | 124 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2772 | 0.030 |
Why?
|
Radiation Dosage | 2 | 2017 | 1956 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14641 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8946 | 0.030 |
Why?
|
Rectum | 1 | 2017 | 895 | 0.020 |
Why?
|
Swine | 1 | 2021 | 5892 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20500 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2017 | 1166 | 0.020 |
Why?
|
Tumor Burden | 1 | 2016 | 1893 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8144 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 13959 | 0.020 |
Why?
|
Body Burden | 1 | 2010 | 158 | 0.020 |
Why?
|
Computer-Aided Design | 1 | 2011 | 298 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 843 | 0.020 |
Why?
|
Vagina | 1 | 2012 | 838 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6821 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6493 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23681 | 0.020 |
Why?
|
Animals | 3 | 2024 | 167777 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 39873 | 0.010 |
Why?
|
Equipment Design | 1 | 2011 | 3507 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2017 | 80170 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18125 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5861 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2016 | 58681 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2016 | 64379 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12721 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11152 | 0.010 |
Why?
|
Adult | 3 | 2017 | 219916 | 0.010 |
Why?
|
Female | 4 | 2017 | 390316 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11709 | 0.010 |
Why?
|
Neoplasms | 1 | 2024 | 22030 | 0.010 |
Why?
|
Aged | 2 | 2016 | 168217 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39060 | 0.010 |
Why?
|
Middle Aged | 2 | 2016 | 219560 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 58808 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 87888 | 0.000 |
Why?
|